Cargando…

Application whole exome sequencing for the clinical molecular diagnosis of patients with Duchenne muscular dystrophy; identification of four novel nonsense mutations in four unrelated Chinese DMD patients

BACKGROUND: Duchenne muscular dystrophy (DMD) is the most common form of inherited muscular dystrophy. Germline mutations in dystrophin (DMD) gene cause DMD, with a X‐linked recessive mode of inheritance. Patients with DMD are usually characterized by weakness of muscle, usually started since childh...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yan, Yang, Weikang, Wen, Guoming, Wu, Yanxia, Jing, Zhiliang, Li, Dazhou, Tang, Minshan, Liu, Guanglong, Wei, Xuxuan, Zhong, Yan, Li, Yanhua, Deng, Yongjian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6503051/
https://www.ncbi.nlm.nih.gov/pubmed/30938079
http://dx.doi.org/10.1002/mgg3.622
_version_ 1783416342757507072
author Zhang, Yan
Yang, Weikang
Wen, Guoming
Wu, Yanxia
Jing, Zhiliang
Li, Dazhou
Tang, Minshan
Liu, Guanglong
Wei, Xuxuan
Zhong, Yan
Li, Yanhua
Deng, Yongjian
author_facet Zhang, Yan
Yang, Weikang
Wen, Guoming
Wu, Yanxia
Jing, Zhiliang
Li, Dazhou
Tang, Minshan
Liu, Guanglong
Wei, Xuxuan
Zhong, Yan
Li, Yanhua
Deng, Yongjian
author_sort Zhang, Yan
collection PubMed
description BACKGROUND: Duchenne muscular dystrophy (DMD) is the most common form of inherited muscular dystrophy. Germline mutations in dystrophin (DMD) gene cause DMD, with a X‐linked recessive mode of inheritance. Patients with DMD are usually characterized by weakness of muscle, usually started since childhood and gradually the patient will unable to stand and walk. METHODS: In our present study, we identified four unrelated Chinese patients with DMD from four Chinese families. Whole exome sequencing was performed for genetic molecular analysis for these probands. RESULTS: Whole exome sequencing and confirmatory Sanger sequencing identified four novel nonsense mutations in these four unrelated Chinese patients, respectively. All these four mutations lead to the formation of a truncated DMD protein by formation of a premature stop codon. According to the variant interpretation guidelines of American College of Medical Genetics and Genomics (ACMG), these four novel nonsense mutations are categorized as “likely pathogenic” variants. CONCLUSION: Our present finding not only identified four novel loss‐of‐function mutations in dystrophin (DMD) gene but also strongly emphasized the significance of whole exome sequencing as the most efficient way of identifying the candidate genes and mutations which enables us for easy and rapid clinical diagnosis, follow‐up, and management of DMD patients.
format Online
Article
Text
id pubmed-6503051
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-65030512019-05-10 Application whole exome sequencing for the clinical molecular diagnosis of patients with Duchenne muscular dystrophy; identification of four novel nonsense mutations in four unrelated Chinese DMD patients Zhang, Yan Yang, Weikang Wen, Guoming Wu, Yanxia Jing, Zhiliang Li, Dazhou Tang, Minshan Liu, Guanglong Wei, Xuxuan Zhong, Yan Li, Yanhua Deng, Yongjian Mol Genet Genomic Med Original Articles BACKGROUND: Duchenne muscular dystrophy (DMD) is the most common form of inherited muscular dystrophy. Germline mutations in dystrophin (DMD) gene cause DMD, with a X‐linked recessive mode of inheritance. Patients with DMD are usually characterized by weakness of muscle, usually started since childhood and gradually the patient will unable to stand and walk. METHODS: In our present study, we identified four unrelated Chinese patients with DMD from four Chinese families. Whole exome sequencing was performed for genetic molecular analysis for these probands. RESULTS: Whole exome sequencing and confirmatory Sanger sequencing identified four novel nonsense mutations in these four unrelated Chinese patients, respectively. All these four mutations lead to the formation of a truncated DMD protein by formation of a premature stop codon. According to the variant interpretation guidelines of American College of Medical Genetics and Genomics (ACMG), these four novel nonsense mutations are categorized as “likely pathogenic” variants. CONCLUSION: Our present finding not only identified four novel loss‐of‐function mutations in dystrophin (DMD) gene but also strongly emphasized the significance of whole exome sequencing as the most efficient way of identifying the candidate genes and mutations which enables us for easy and rapid clinical diagnosis, follow‐up, and management of DMD patients. John Wiley and Sons Inc. 2019-04-01 /pmc/articles/PMC6503051/ /pubmed/30938079 http://dx.doi.org/10.1002/mgg3.622 Text en © 2019 The Authors. Molecular Genetics & Genomic Medicine published by Wiley Periodicals, Inc. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Zhang, Yan
Yang, Weikang
Wen, Guoming
Wu, Yanxia
Jing, Zhiliang
Li, Dazhou
Tang, Minshan
Liu, Guanglong
Wei, Xuxuan
Zhong, Yan
Li, Yanhua
Deng, Yongjian
Application whole exome sequencing for the clinical molecular diagnosis of patients with Duchenne muscular dystrophy; identification of four novel nonsense mutations in four unrelated Chinese DMD patients
title Application whole exome sequencing for the clinical molecular diagnosis of patients with Duchenne muscular dystrophy; identification of four novel nonsense mutations in four unrelated Chinese DMD patients
title_full Application whole exome sequencing for the clinical molecular diagnosis of patients with Duchenne muscular dystrophy; identification of four novel nonsense mutations in four unrelated Chinese DMD patients
title_fullStr Application whole exome sequencing for the clinical molecular diagnosis of patients with Duchenne muscular dystrophy; identification of four novel nonsense mutations in four unrelated Chinese DMD patients
title_full_unstemmed Application whole exome sequencing for the clinical molecular diagnosis of patients with Duchenne muscular dystrophy; identification of four novel nonsense mutations in four unrelated Chinese DMD patients
title_short Application whole exome sequencing for the clinical molecular diagnosis of patients with Duchenne muscular dystrophy; identification of four novel nonsense mutations in four unrelated Chinese DMD patients
title_sort application whole exome sequencing for the clinical molecular diagnosis of patients with duchenne muscular dystrophy; identification of four novel nonsense mutations in four unrelated chinese dmd patients
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6503051/
https://www.ncbi.nlm.nih.gov/pubmed/30938079
http://dx.doi.org/10.1002/mgg3.622
work_keys_str_mv AT zhangyan applicationwholeexomesequencingfortheclinicalmoleculardiagnosisofpatientswithduchennemusculardystrophyidentificationoffournovelnonsensemutationsinfourunrelatedchinesedmdpatients
AT yangweikang applicationwholeexomesequencingfortheclinicalmoleculardiagnosisofpatientswithduchennemusculardystrophyidentificationoffournovelnonsensemutationsinfourunrelatedchinesedmdpatients
AT wenguoming applicationwholeexomesequencingfortheclinicalmoleculardiagnosisofpatientswithduchennemusculardystrophyidentificationoffournovelnonsensemutationsinfourunrelatedchinesedmdpatients
AT wuyanxia applicationwholeexomesequencingfortheclinicalmoleculardiagnosisofpatientswithduchennemusculardystrophyidentificationoffournovelnonsensemutationsinfourunrelatedchinesedmdpatients
AT jingzhiliang applicationwholeexomesequencingfortheclinicalmoleculardiagnosisofpatientswithduchennemusculardystrophyidentificationoffournovelnonsensemutationsinfourunrelatedchinesedmdpatients
AT lidazhou applicationwholeexomesequencingfortheclinicalmoleculardiagnosisofpatientswithduchennemusculardystrophyidentificationoffournovelnonsensemutationsinfourunrelatedchinesedmdpatients
AT tangminshan applicationwholeexomesequencingfortheclinicalmoleculardiagnosisofpatientswithduchennemusculardystrophyidentificationoffournovelnonsensemutationsinfourunrelatedchinesedmdpatients
AT liuguanglong applicationwholeexomesequencingfortheclinicalmoleculardiagnosisofpatientswithduchennemusculardystrophyidentificationoffournovelnonsensemutationsinfourunrelatedchinesedmdpatients
AT weixuxuan applicationwholeexomesequencingfortheclinicalmoleculardiagnosisofpatientswithduchennemusculardystrophyidentificationoffournovelnonsensemutationsinfourunrelatedchinesedmdpatients
AT zhongyan applicationwholeexomesequencingfortheclinicalmoleculardiagnosisofpatientswithduchennemusculardystrophyidentificationoffournovelnonsensemutationsinfourunrelatedchinesedmdpatients
AT liyanhua applicationwholeexomesequencingfortheclinicalmoleculardiagnosisofpatientswithduchennemusculardystrophyidentificationoffournovelnonsensemutationsinfourunrelatedchinesedmdpatients
AT dengyongjian applicationwholeexomesequencingfortheclinicalmoleculardiagnosisofpatientswithduchennemusculardystrophyidentificationoffournovelnonsensemutationsinfourunrelatedchinesedmdpatients